Enterobacter cloacae: PCR Detection and Clinical Overview

Enterobacter cloacae is a Gram-negative, short rod-shaped bacterium measuring approximately 0.6–1.1 μm in width and 1.2–3.0 μm in length.

It possesses 6–8 peritrichous flagella, making it motile. It does not form spores or capsules.

The organism is widely distributed in nature, including in human and animal feces, soil, water, and plants, and is also part of the normal human gut flora.

As a facultative anaerobe, it grows well on standard laboratory media, forming large, moist, mucoid colonies.

The optimal growth temperature is approximately 30°C, although it can grow over a broad temperature range.

On blood agar, colonies are typically non-hemolytic.

On EMB agar, colonies appear pink and mucoid, while on MacConkey agar they are pink to red and mucoid due to lactose fermentation.

On SS agar, colonies appear white or off-white if growth occurs.

Biochemically, Enterobacter cloacae ferments glucose with acid and gas production, but does not produce gas at 44.5°C.

TSI results typically show acid/acid with or without gas production, and no hydrogen sulfide production. Citrate (CIT) and urease (URE) tests are positive, while indole (IND) is negative.

As an opportunistic pathogen, Enterobacter cloacae can infect multiple organ systems.

Common infections include skin and soft tissue infections, urinary tract infections, respiratory infections such as pneumonia, septicemia, meningitis, and peritonitis.

High-risk groups include elderly individuals, patients with chronic diseases (e.g., diabetes, COPD), immunocompromised individuals, hospitalized patients, and healthcare workers.

Transmission routes include direct contact, environmental exposure, respiratory droplets, ingestion of contaminated food or water, and nosocomial transmission via contaminated medical equipment.

Clinical symptoms vary depending on the site of infection and patient condition.

Common symptoms include fever, cough, purulent sputum, urinary symptoms (frequency, urgency, dysuria), abdominal pain, nausea, and vomiting.

Severe infections may lead to septicemia, characterized by high fever, chills, petechiae, hepatosplenomegaly, and systemic inflammation.

Treatment typically involves antibiotic therapy tailored to susceptibility testing, as Enterobacter cloacae often exhibits resistance to multiple antibiotics.

Laboratory diagnosis includes culture, biochemical testing, and molecular methods.

Real-time PCR (qPCR) enables rapid, sensitive, and specific detection of Enterobacter cloacae, making it highly valuable for clinical diagnostics, environmental monitoring, and infection control.

Molecular detection can also assist in identifying resistance-associated genes, supporting appropriate antimicrobial therapy decisions.

Effective prevention relies on strict infection control measures in healthcare settings, including proper sterilization and disinfection of medical equipment.

High-risk populations should be closely monitored and protected.

Rational use of antibiotics is critical to prevent antimicrobial resistance and maintain microbiota balance.

Food safety and hygiene practices should be strengthened to reduce transmission through contaminated food and water.

Public awareness and good personal hygiene habits are essential in reducing infection risk.